Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
206 participants
INTERVENTIONAL
2007-12-31
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Purevision Contact Lens #1
PureVision Soft Contact Lens Design (currently marketed)
Currently Marketed PureVision Contact Lens.
Contact lens for continuous wear
PureVision Contact Lens #2
Redesign of the currently marketed PureVision soft contact lens.
Alternate Design of the PureVision Contact Lens.
Contact lens for continuous wear
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Currently Marketed PureVision Contact Lens.
Contact lens for continuous wear
Alternate Design of the PureVision Contact Lens.
Contact lens for continuous wear
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* VA correctable to 0.3 logMAR or better (driving vision)
* Clear central cornea
Exclusion Criteria
* using systemic or topical medications
* wear monovision, multifocal or toric contact lenses
* Any grade 2 or greater slit lamp findings
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bausch & Lomb Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gerard Cairns, MCOptom, PhD
Role: STUDY_DIRECTOR
Bausch & Lomb Incorporated
Benny Chian, MCOptom
Role: PRINCIPAL_INVESTIGATOR
Laser Focus Sdn Bhd, Vision Correction Centre
Harvey Siy Uy, MD
Role: PRINCIPAL_INVESTIGATOR
Asian Eye Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laser Focus Sdn Bhd, Vision Correction Centre
Johor Bahru, Johor Bahru, Malaysia
Asian Eye Institute
Makati City, , Philippines
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
544
Identifier Type: -
Identifier Source: org_study_id